Bitterman Robert J 4
4 · Phio Pharmaceuticals Corp. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Bitterman Robert J
DirectorChairman, Pres. & CEO
Transactions
- Tax Payment
Common stock, $0.0001 par value
2024-02-20$0.76/sh−1,804$1,371→ 16,490 total
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
- [F2]Includes shares of common stock underlying unvested restricted stock units.